(Q37355471)

19 August 2017

1 reference

title

Does reversal of oxidative stress and inflammation provide vascular protection? (English)

1 reference

19 August 2017

0 references

0 references

Kwang Kon Koh

1

1 reference

19 August 2017

Pyung Chun Oh

series ordinal

2

1 reference

19 August 2017

Michael J Quon

series ordinal

3

1 reference

19 August 2017

Michael J Quon

series ordinal

4

1 reference

19 August 2017

20 December 2008

1 reference

19 August 2017

Cardiovascular Research

1 reference

19 August 2017

81

1 reference

19 August 2017

4

1 reference

19 August 2017

649-659

1 reference

Effects of statins on vascular wall: vasomotor function, inflammation, and plaque stability

19 August 2017

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN354

Effects of estrogen on the vascular wall: vasomotor function and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN354

Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN354

Inflammatory markers and the metabolic syndrome: insights from therapeutic interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN354

The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN354

Structure, regulation and evolution of Nox-family NADPH oxidases that produce reactive oxygen species

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN354

Differential vascular functions of Nox family NADPH oxidases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN354

NADPH oxidases: new kids on the block

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN354

Mechanisms of reactive oxygen species-dependent downregulation of insulin receptor substrate-1 by angiotensin II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN354

Upregulation of the vascular NAD(P)H-oxidase isoforms Nox1 and Nox4 by the renin-angiotensin system in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN354

Upregulation of Nox-based NAD(P)H oxidases in restenosis after carotid injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN354

Angiotensin II stimulates endothelial vascular cell adhesion molecule-1 via nuclear factor-kappaB activation induced by intracellular oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN354

Dimethylarginine dimethylaminohydrolase overexpression enhances insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN354

Increased oxidative stress in experimental renovascular hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN354

Hypercholesterolemia impairs myocardial perfusion and permeability: role of oxidative stress and endogenous scavenging activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN354

Hypercholesterolemia and hypertension have synergistic deleterious effects on coronary endothelial function

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN354

Role of superoxide in angiotensin II-induced but not catecholamine-induced hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN354

Angiotensin II-induced hypertension accelerates the development of atherosclerosis in apoE-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN354

Oxidized LDL upregulates angiotensin II type 1 receptor expression in cultured human coronary artery endothelial cells: the potential role of transcription factor NF-kappaB

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN354

The angiotensin-converting enzyme inhibitor, fosinopril, and the angiotensin II receptor antagonist, losartan, inhibit LDL oxidation and attenuate atherosclerosis independent of lowering blood pressure in apolipoprotein E deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN354

Angiotensin II stimulates intercellular adhesion molecule-1 (ICAM-1) expression by human vascular endothelial cells and increases soluble ICAM-1 release in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN354

Pleiotropic effects of angiotensin II receptor blocker in hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN354

Anti-inflammatory and metabolic effects of candesartan in hypertensive patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN354

Losartan-dependent regression of myocardial fibrosis is associated with reduction of left ventricular chamber stiffness in hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN354

Comparative effects of valsartan versus amlodipine on left ventricular mass and reactive oxygen species formation by monocytes in hypertensive patients with left ventricular hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN354

Simvastatin prevents angiotensin II-induced cardiac alteration and oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN354

A novel pleiotropic effect of statins: prevention of cardiac hypertrophy by cholesterol-independent mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN354

Atorvastatin protects against cerebral infarction via inhibition of NADPH oxidase-derived superoxide in ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN354

Modulating angiotensin II-induced inflammation by HMG Co-A reductase inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN354

Critical role for FoxO3a-dependent regulation of p21CIP1/WAF1 in response to statin signaling in cardiac myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN354

Adiponectin and cardiovascular disease: response to therapeutic interventions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN354

Fluvastatin enhances the inhibitory effects of a selective AT1 receptor blocker, valsartan, on atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN354

Additive beneficial effects of losartan combined with simvastatin in the treatment of hypercholesterolemic, hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN354

Vascular and metabolic effects of combined therapy with ramipril and simvastatin in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN354

Effect of atorvastatin and irbesartan, alone and in combination, on postprandial endothelial dysfunction, oxidative stress, and inflammation in type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN354

Inflammatory activation during coronary artery surgery and its dose-dependent modulation by statin/ACE-inhibitor combination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN354

Beneficial vascular and metabolic effects of peroxisome proliferator-activated receptor-alpha activators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN354

Peroxisome proliferator-activated receptor alpha agonists increase nitric oxide synthase expression in vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN354

Myocardial fibrosis and diastolic dysfunction in deoxycorticosterone acetate-salt hypertensive rats is ameliorated by the peroxisome proliferator-activated receptor-alpha activator fenofibrate, partly by suppressing inflammatory responses associated

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN354

Fenofibrate lowers abdominal and skeletal adiposity and improves insulin sensitivity in OLETF rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN354

Effect of PPAR-alpha and -gamma agonist on the expression of visfatin, adiponectin, and TNF-alpha in visceral fat of OLETF rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN354

Antiinflammatory and antiarteriosclerotic effects of pioglitazone

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN354

Antioxidative, Antinitrative, and Vasculoprotective Effects of a Peroxisome Proliferator–Activated Receptor-γ Agonist in Hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN354

Peroxisome proliferator-activated receptor gamma: implications for cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN354

Peroxisome proliferator-activated receptor gamma ligands increase release of nitric oxide from endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN354

Peroxisome proliferator-activated receptor-gamma ligands regulate endothelial membrane superoxide production

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN354

Fenofibrate therapy ameliorates fasting and postprandial lipoproteinemia, oxidative stress, and the inflammatory response in subjects with hypertriglyceridemia and the metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN354

Effects of pioglitazone on lipoproteins, inflammatory markers, and adipokines in nondiabetic patients with metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN354

Increased high-density lipoprotein cholesterol predicts the pioglitazone-mediated reduction of carotid intima-media thickness progression in patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN354

Angiotensin II is associated with activation of NF-kappaB-mediated genes and downregulation of PPARs

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN354

PPARalpha activator effects on Ang II-induced vascular oxidative stress and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN354

Angiotensin type 1 receptor blockers induce peroxisome proliferator-activated receptor-gamma activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN354

Beneficial effects of pioglitazone on hypertensive cardiovascular injury are enhanced by combination with candesartan

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN354

Additive beneficial effects of fenofibrate combined with candesartan in the treatment of hypertriglyceridemic hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN354

Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN354

Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN354

Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN354

Fibrate and statin synergistically increase the transcriptional activities of PPARalpha/RXRalpha and decrease the transactivation of NFkappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN354

Acute antiinflammatory properties of statins involve peroxisome proliferator-activated receptor-alpha via inhibition of the protein kinase C signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN354

Additive beneficial effects of fenofibrate combined with atorvastatin in the treatment of combined hyperlipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN354

Statin-fibrate combination therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN354

Cerivastatin and reports of fatal rhabdomyolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN354

Effectiveness and tolerability of simvastatin plus fenofibrate for combined hyperlipidemia (the SAFARI trial).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN354

Vascular and metabolic effects of treatment of combined hyperlipidemia: focus on statins and fibrates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN354

Reporting rate of rhabdomyolysis with fenofibrate + statin versus gemfibrozil + any statin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN354

Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN354

Inhibition of oxidative stress and improvement of endothelial function by amlodipine in angiotensin II-infused rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN354

A calcium channel blocker activates both ecto-5′-nucleotidase and NO synthase in HUVEC

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN354

Amlodipine increases endothelial nitric oxide by dual mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN354

Effect of amlodipine compared to atenolol on small arteries of previously untreated essential hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN354

Different effect of antihypertensive drugs on conduit artery endothelial function

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN354

Actions of mibefradil, efonidipine and nifedipine block of recombinant T- and L-type Ca channels with distinct inhibitory mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN354

Ascorbate restores endothelium-dependent vasodilation impaired by acute hyperglycemia in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN354

Antioxidant vitamins C and E improve endothelial function in children with hyperlipidemia: Endothelial Assessment of Risk from Lipids in Youth (EARLY) Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN354

Vitamin E consumption and the risk of coronary disease in women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN354

Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN354

Vitamin E in the primary prevention of cardiovascular disease and cancer: the Women's Health Study: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN354

A randomized factorial trial of vitamins C and E and beta carotene in the secondary prevention of cardiovascular events in women: results from the Women's Antioxidant Cardiovascular Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN354

Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN354

High-dose oral vitamin C partially replenishes vitamin C levels in patients with Type 2 diabetes and low vitamin C levels but does not improve endothelial dysfunction or insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN354

The union of vascular and metabolic actions of insulin in sickness and in health.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN354

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN354

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre ra

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN354

A strategy to reduce cardiovascular disease by more than 80%

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN354

Impact of candesartan on nonfatal myocardial infarction and cardiovascular death in patients with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN354

Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (A

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN354

Combination therapy for treatment or prevention of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN354

Effect of Vitamin C on Forearm Blood Flow and Glucose Metabolism in Essential Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCVR%2FCVN354

21 January 2018

Identifiers

DOI

10.1093/CVR/CVN354

1 reference

19 August 2017

1 reference